Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.

Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma. Nucl Med Biol. 2008 Aug; 35 Suppl 1:S35-48.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.